How brain fluid dynamics drive cancer spread—and ways to fight back Updated on: October 03,2025 0 How brain fluid dynamics drive cancer spread—and ways to fight back Updated on:October 03,2025 0
Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests Updated on: October 03,2025 0 Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests Updated on:October 03,2025 0
Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics Updated on: October 03,2025 0 Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics Updated on:October 03,2025 0
Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion Updated on: October 03,2025 0 Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion Updated on:October 03,2025 0
Study highlights communication gaps and need for shared decision-making in lung cancer diagnosis Updated on: October 03,2025 0 Study highlights communication gaps and need for shared decision-making in lung cancer diagnosis Updated on:October 03,2025 0
Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC Updated on: October 03,2025 0 Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC Updated on:October 03,2025 0
Clinical study deepens understanding of mesothelioma, opens the door to potential treatment options Updated on: October 03,2025 0 Clinical study deepens understanding of mesothelioma, opens the door to potential treatment options Updated on:October 03,2025 0
Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC Updated on: October 03,2025 0 Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC Updated on:October 03,2025 0
New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer Updated on: October 03,2025 0 New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer Updated on:October 03,2025 0
Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC Updated on: October 03,2025 0 Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC Updated on:October 03,2025 0